Scantox is the leading Nordic preclinical GLP-accredited CRO, focused on pharmacology and regulatory toxicology. We are headquartered in Denmark, in the same location as where the company was originally founded, and in addition Scantox has subsidiaries in Sweden.
Based on decades of experience, we are a trusted partner for product development services within the pharmaceutical, biotech and medical devices industries, and a globally recognized leader for our expertise with Göttingen Minipigs. Our services enable clients to progress their drug or device development based on solid data to the highest technical and scientific standards.
- Local tolerance studies
- Endotoxin testing
- Safety pharmacology
- Wound healing studies
Founded in 1977, Scantox is today owned by Impilo, the leading Nordic healthcare investment company.